{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:09:20Z","timestamp":1778962160986,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.remnie.2025.500184","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T12:02:21Z","timestamp":1750420941000},"page":"500184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond the standard: Enhancing prostate bed and regional lymph node detection in prostate cancer patients with early and delayed imaging in [68 Ga]Ga-PSMA-11 PET\/CT"],"prefix":"10.1016","volume":"45","author":[{"given":"A.","family":"Aghaee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Bakhshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Roshanravan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Norouzbeigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Dadgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Askari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Aryana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Shafiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sadeghpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2025.500184_bib0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11934-007-0013-9","article-title":"The spectrum of prostate cancer care: from curative intent to palliation","volume":"8","author":"Ali","year":"2007","journal-title":"Curr Urol Rep."},{"key":"10.1016\/j.remnie.2025.500184_bib0010","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.acra.2018.05.020","article-title":"68Ga-PSMA PET\/CT in patients with rising prostatic-specific antigen after definitive treatment of prostate cancer: detection efficacy and diagnostic accuracy","volume":"26","author":"Hamed","year":"2019","journal-title":"Acad Radiol."},{"key":"10.1016\/j.remnie.2025.500184_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2967\/jnumed.120.262250","article-title":"The added value of 18F-FDG PET\/CT compared with 68Ga-PSMA PET\/CT in patients with castration-resistant prostate cancer","volume":"63","author":"Chen","year":"2022","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500184_bib0020","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.2967\/jnumed.116.172627","article-title":"68Ga-PSMA PET\/CT detects the location and extent of primary prostate cancer","volume":"57","author":"Fendler","year":"2016","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500184_bib0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2214\/AJR.20.23912","article-title":"Diagnostic accuracy of 68Ga-PSMA PET\/CT for initial detection in patients with suspected prostate cancer: a systematic review and meta-analysis","volume":"216","author":"Satapathy","year":"2021","journal-title":"Am J Roentgenol."},{"key":"10.1016\/j.remnie.2025.500184_bib0030","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.21873\/invivo.13211","article-title":"68Ga-PSMA PET\/CT and prostate cancer diagnosis: which SUVmax value?","volume":"37","author":"Pepe","year":"2023","journal-title":"In Vivo."},{"key":"10.1016\/j.remnie.2025.500184_bib0035","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2967\/jnumed.119.236059","article-title":"Diagnostic value of 68Ga-PSMA PET\/CT for detection of phosphatase and tensin homolog expression in prostate cancer: a pilot study","volume":"61","author":"Wang","year":"2020","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500184_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/diagnostics8010016","article-title":"Review of gallium-68 PSMA PET\/CT imaging in the management of prostate cancer","volume":"8","author":"Lenzo","year":"2018","journal-title":"Diagnostics."},{"key":"10.1016\/j.remnie.2025.500184_bib0045","article-title":"68Ga-PSMA PET\/CT for the evaluation of metastasis in patients with prostate cancer: a systematic review and meta-analysis","author":"Zhou","year":"2022","journal-title":"Hellenic J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500184_bib0050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","article-title":"PET imaging with a [68 Ga] gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions","volume":"40","author":"Afshar-Oromieh","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500184_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40644-016-0072-6","article-title":"68 Ga-PSMA ligand PET\/CT in patients with prostate cancer: how we review and report","volume":"16","author":"Rauscher","year":"2016","journal-title":"Cancer Imaging."},{"key":"10.1016\/j.remnie.2025.500184_bib0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00259-016-3594-z","article-title":"Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68 Ga-PSMA-11-PET of PET\/CT and PET\/MRI: comparison with mpMRI integrated in simultaneous PET\/MRI","volume":"44","author":"Freitag","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500184_bib0065","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2967\/jnumed.116.183483","article-title":"The clinical impact of additional late PET\/CT imaging with 68Ga-PSMA-11 (HBED-CC) in the diagnosis of prostate cancer","volume":"58","author":"Afshar-Oromieh","year":"2017","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500184_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13550-017-0261-8","article-title":"Impact of PET acquisition durations on image quality and lesion detectability in whole-body 68 Ga-PSMA PET-MRI","volume":"7","author":"Noto","year":"2017","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.remnie.2025.500184_bib0075","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1007\/s00330-016-4308-4","article-title":"68 Ga-PSMA I&T PET\/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging","volume":"26","author":"Derlin","year":"2016","journal-title":"Eur Radiol."},{"key":"10.1016\/j.remnie.2025.500184_bib0080","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00259-016-3578-z","article-title":"Early dynamic imaging in 68 Ga-PSMA-11 PET\/CT allows discrimination of urinary bladder activity and prostate cancer lesions","volume":"44","author":"Uprimny","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500184_bib0085","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/MNM.0000000000000290","article-title":"Evaluation of PSMA PET\/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging","volume":"36","author":"Kabasakal","year":"2015","journal-title":"Nucl Med Commun."},{"key":"10.1016\/j.remnie.2025.500184_bib0090","doi-asserted-by":"crossref","first-page":"111073","DOI":"10.18632\/oncotarget.22441","article-title":"Diagnostic performance of (68)Gallium-PSMA-11 PET\/CT to detect significant prostate cancer and comparison with (18)FEC PET\/CT","volume":"8","author":"Hoffmann","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.remnie.2025.500184_bib0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1148\/radiol.2021204093","article-title":"Diagnostic performance of 68Ga prostate-specific membrane antigen PET\/MRI compared with multiparametric MRI for detecting clinically significant prostate cancer","volume":"301","author":"Margel","year":"2021","journal-title":"Radiology."},{"key":"10.1016\/j.remnie.2025.500184_bib0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13244-020-00926-y","article-title":"Lesion-to-background ratio threshold value of SUVmax of simultaneous [(68)Ga]Ga-PSMA-11 PET\/MRI imaging in patients with prostate cancer","volume":"11","author":"Zhao","year":"2020","journal-title":"Insights Imaging."},{"key":"10.1016\/j.remnie.2025.500184_bib0105","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2967\/jnumed.117.198119","article-title":"Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-Ligand PET\/CT","volume":"59","author":"Eiber","year":"2018","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500184_bib0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE\u00a0V2)","volume":"83","author":"Seifert","year":"2023","journal-title":"Eur Urol."},{"key":"10.1016\/j.remnie.2025.500184_bib0115","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00259-016-3578-z","article-title":"Early dynamic imaging in 68Ga-PSMA-11 PET\/CT allows discrimination of urinary bladder activity and prostate cancer lesions","volume":"44","author":"Uprimny","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500184_bib0120","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2967\/jnumed.115.160382","article-title":"Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET\/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy","volume":"56","author":"Morigi","year":"2015","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500184_bib0125","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/bju.13397","article-title":"68Ga\u2010PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment","volume":"117","author":"van Leeuwen","year":"2016","journal-title":"BJU Int."},{"key":"10.1016\/j.remnie.2025.500184_bib0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00259-015-3240-1","article-title":"Extent of disease in recurrent prostate cancer determined by [68 Ga] PSMA-HBED-CC PET\/CT in relation to PSA levels, PSA doubling time and Gleason score","volume":"43","author":"Verburg","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500184_bib0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00259-015-3188-1","article-title":"68 Ga-PSMA-11 PET\/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients","volume":"43","author":"Sterzing","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500184_bib0140","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","article-title":"Sensitivity, specificity, and predictors of positive 68Ga\u2013prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis","volume":"70","author":"Perera","year":"2016","journal-title":"Eur Urol."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:47:16Z","timestamp":1778960836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808925000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2253808925000886"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500184","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond the standard: Enhancing prostate bed and regional lymph node detection in prostate cancer patients with early and delayed imaging in [68 Ga]Ga-PSMA-11 PET\/CT","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2025.500184","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"500184"}}